NCT06582862

Brief Summary

This study aims to analyze the effects of aerobic and anaerobic exercise on health at the molecular level. By examining these effects, the study seeks to provide the public with insights into which types of exercise offer the most significant health benefits. Participants will engage in aerobic and anaerobic exercises for one month, with 5 mL of venous blood collected by experienced phlebotomists both before and after the exercise period. While blood collection may cause mild discomfort and temporary bruising, these symptoms should subside within a few days. The collected blood will be processed to separate plasma and leukocytes for the assessment of oxidative damage, lipid profile and cellular fitness parameters. The oxidative damage markers to be measured include malondialdehyde (MDA) levels, H2O2, and antioxidants such as total antioxidant capacity, superoxide dismutase, and glutathione peroxidase. Cellular fitness will be evaluated by measuring mitochondrial biogenesis markers (succinate dehydrogenase and PGC-1A), ATP levels, and ATPase inhibitor levels. The benefits for the participants, they will receive include a laboratory assessment to evaluate cell damage, lipid profiles, and mitochondrial function. Additionally, the study results will help identify the most beneficial type of physical exercise for optimal health.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2024

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

August 27, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

September 3, 2024

Completed
27 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2024

Completed
Last Updated

September 3, 2024

Status Verified

August 1, 2024

Enrollment Period

4 months

First QC Date

August 27, 2024

Last Update Submit

August 30, 2024

Conditions

Outcome Measures

Primary Outcomes (5)

  • Concentration of Malondialdehyde (MDA)

    MDA in nmoL/mL is measured using spectrophotometer from the subject's plasma

    1 month

  • Concentration of Hydrogen Peroxide

    Hydrogen peroxide in mmol/L is measured using spectrophotometer from the subject's plasma

    1 month

  • Concentration of Superoxide dismutase (SOD)

    SOD in U/mL is measured using spectrophotometer from the subject's plasma

    1 month

  • Concentration of Total Antioxidant Capacity

    Total Antioxidant Capacity in U/mL is measured using spectrophotometer from the subject's plasma

    1 month

  • Concentration of Glutathione Peroxidase (GPx)

    GPx in in U/mL is measured using spectrophotometer from the subject's plasma

    1 month

Secondary Outcomes (4)

  • Concentration of Succinate Dehydrogenase (SDH)

    1 month

  • Concentration of Peroxisome proliferator-activated receptor-gamma coactivator (PGC)-1alpha

    1 month

  • Concentration of Adenosine triphosphate (ATP)

    1 month

  • Concentration of ATPase inhibitor

    1 month

Study Arms (2)

Pre aerobic exercise treatment

EXPERIMENTAL

Subject will do aerobic exercise 3 times a week for 1 month. The training program includes the following: Week 1 consists of interval running (2 sets of 10 repetitions of 400 meters each) with 3 minutes of rest between repetitions and 10 minutes of rest between sets. Week 2 transitions to continuous running for 15-20 minutes. Week 3 involves 30 minutes of cross-country running. In Week 4, the program returns to interval running as in Week 1.

Other: Exercise

Pre anaerobic exercise treatment

EXPERIMENTAL

Subject will do anerobic exercise 3 times a week for 1 month. The sprint training program includes the following: In Weeks 1 and 3, perform sprints of 20 m, 40 m, 60 m, and 80 m, with 2 sets of 5 repetitions each, allowing 5 minutes of rest between repetitions and 10 minutes of rest between sets. In Weeks 2 and 4, run 2 sets of 5 repetitions of 50 m sprints, with 5 minutes of rest between repetitions and 10 minutes between sets.

Other: Exercise

Interventions

Subjects will do aerobic and anaerobic exercise

Pre aerobic exercise treatmentPre anaerobic exercise treatment

Eligibility Criteria

Age18 Years - 23 Years
Sexmale(Gender-based eligibility)
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Male, aged 18-23.
  • body weight of 56-70 kg and a height of 158-175 cm.
  • Systolic blood pressure values below 130 mmHg, and diastolic blood pressure below 90 mmHg.
  • maximum oxygen consumption (VO2max) is calculated to be greater than 40 mL/(kg-minute).

You may not qualify if:

  • fever
  • having chronic diseases (heart disease, lung disease)
  • smoking

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Medicine Universitas Indonesia

Jakarta Pusat, Jakarta Special Capital Region, 10430, Indonesia

Location

MeSH Terms

Interventions

Exercise

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Novi Hardiany

    Fakultas Kedokteran Universitas Indonesia

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Model Details: Participants will be divided into 2 groups. One group will do aerobic exercise and other group will do anaerobic exercise
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Coordinator

Study Record Dates

First Submitted

August 27, 2024

First Posted

September 3, 2024

Study Start

June 1, 2024

Primary Completion

September 30, 2024

Study Completion

November 30, 2024

Last Updated

September 3, 2024

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will not share

Locations